PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma.
about
Enhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non-small-cell Lung CancerDihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer.PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line.Molecular characteristics of uterine sarcomas.Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Primary leiomyosarcoma in the colon: A case report.
P2860
Q36192506-023BE72C-3AD0-423C-B55D-D514F959F466Q37325666-8301C70E-F4DE-4033-BD1C-948B89B18609Q37702626-47D0C1E3-8AF0-45A9-8EE6-E0B88DF2CD4BQ37707021-F23FA2AB-88BA-4C81-8E05-960C5E0C274CQ38704263-FE1105E3-56F5-4246-AA9B-684F43C3B76EQ38881796-4D4897CD-F95D-4434-9F9B-3CA625E6E38BQ48135854-5EA4C188-F5CD-44DD-95A6-FBF6F62779BFQ50003192-F15D63FB-F9ED-48B9-ACBC-BAAB3181E118
P2860
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PI3K/AKT/mTOR inhibition in co ...... ve therapy for leiomyosarcoma.
@ast
PI3K/AKT/mTOR inhibition in co ...... ve therapy for leiomyosarcoma.
@en
type
label
PI3K/AKT/mTOR inhibition in co ...... ve therapy for leiomyosarcoma.
@ast
PI3K/AKT/mTOR inhibition in co ...... ve therapy for leiomyosarcoma.
@en
prefLabel
PI3K/AKT/mTOR inhibition in co ...... ve therapy for leiomyosarcoma.
@ast
PI3K/AKT/mTOR inhibition in co ...... ve therapy for leiomyosarcoma.
@en
P2093
P2860
P50
P1476
PI3K/AKT/mTOR inhibition in co ...... ive therapy for leiomyosarcoma
@en
P2093
David Uehling
Leah Kabaroff
Methvin Isaac
Michael Prakesch
Paul C Boutros
Rima Al-Awar
Rosemarie Venier
Yael Babichev
P2860
P2888
P356
10.1186/S12967-016-0814-Z
P577
2016-03-08T00:00:00Z
P5875
P6179
1008015503